Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.43 |
| ▸ | NR2E1 | Q9Y466 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | METAP2 | P50579 | 2/20 | 0.39 |
| ▸ | METAP1 | P53582 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3681304 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2CYP2C9CYP2C19AOC3 | |
| SCHEMBL5164702 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2CYP2C9CYP2C19AOC3 | |
| SCHEMBL3683855 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2CYP2C9CYP2C19AOC3 | |
| SCHEMBL3673024 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2CYP2C9CYP2C19AOC3 | |
| SCHEMBL3671134 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2CYP2C9CYP2C19AOC3 | |
| SCHEMBL5144285 | 0.91 | ALDH1A1 (0.43) | ALDH1A1CYP1A2CYP2C9CYP2C19AOC3 | |
| SCHEMBL5144378 | 0.86 | ALDH1A1 (0.42) | ALDH1A1CYP1A2CYP2C9CYP2C19AOC3 | |
| SCHEMBL3682599 | 0.83 | SLC6A4 (0.55) | ALDH1A1CYP1A2CYP2C9CYP2C19AOC3 | |
| SCHEMBL3671168 | 0.81 | SLC6A4 (0.46) | ALDH1A1CYP1A2CYP2C9CYP2C19NR2E1 | |
| SCHEMBL3675707 | 0.81 | AOC3 (0.48) | ALDH1A1CYP1A2CYP2C9CYP2C19AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030027869-A1 | Amine compounds and inhibiting neurotransmitter reuptake | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. | 2003-02-06 | — | — | US | claimed |
| US-20100168246-A1 | AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE | RICHELSON ELLIOTT | 2010-07-01 | — | — | US | disclosed |
| US-20080275272-A1 | AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE | RICHELSON ELLIOTT | 2008-11-06 | — | — | US | disclosed |
| US-20070197662-A1 | AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. | 2007-08-23 | — | — | US | disclosed |
| US-6914080-B2 | Amine compounds and inhibiting neurotransmitter reuptake | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2005-07-05 | — | — | US | disclosed |
| US-6700018-B2 | 3-HYDROXY-2-(2-NAPHTHYL)PENTYLAMINE DERIVATIVES | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2004-03-02 | — | — | US | disclosed |
| US-20030027869-A1 | Amine compounds and inhibiting neurotransmitter reuptake | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. | 2003-02-06 | — | — | US | disclosed |